EZZ Life Science Holdings Ltd Asset Resilience Ratio

Latest as of June 2025: 2.63%

EZZ Life Science Holdings Ltd asset resilience ratio. EZZ Life Science Holdings Ltd (EZZ) has an Asset Resilience Ratio of 2.63% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of EZZ Life Science Holdings Ltd to measure how many days the company can operate on defensive assets alone.

Liquid Assets

AU$891.50K

≈ $630.79K USD Cash + Short-term Investments

Total Assets

AU$33.96 Million

≈ $24.03 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of EZZ Life Science Holdings Ltd (2023–2024)

Asset resilience ratio of EZZ Life Science Holdings Ltd from 2023 to 2024. This chart shows how EZZ Life Science Holdings Ltd's Asset Resilience Ratio has changed over time. Read EZZ Life Science Holdings Ltd total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down EZZ Life Science Holdings Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see EZZ Life Science Holdings Ltd (EZZ) total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$0.00	0%
Short-term Investments	AU$891.50K	2.63%
Total Liquid Assets	AU$891.50K	2.63%

Asset Resilience Insights

Limited Liquidity: EZZ Life Science Holdings Ltd maintains only 2.63% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

EZZ Life Science Holdings Ltd Industry Peers by Asset Resilience Ratio

Compare EZZ Life Science Holdings Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Samsung Biologics Co Ltd KO:207940	Biotechnology	15.21%
Abivax SA PA:ABVX	Biotechnology	2.58%
Tubize-Fin BR:TUB	Biotechnology	2.50%
BB Biotech AG SW:BION	Biotechnology	92.97%
Sinocelltech Group Ltd SHG:688520	Biotechnology	5.27%
Inner Mongolia Furui Med Sci SHE:300049	Biotechnology	1.75%
Mineralys Therapeutics, Inc. Common Stock NASDAQ:MLYS	Biotechnology	78.33%
GH Research PLC NASDAQ:GHRS	Biotechnology	4.73%

EZZ Life Science Holdings Ltd Asset Resilience Ratio by Year (2023–2024)

EZZ Life Science Holdings Ltd asset resilience ratio by year from 2023 to 2024. The table below shows the annual Asset Resilience Ratio data for EZZ Life Science Holdings Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	2.63%	AU$891.50K ≈ $630.79K	AU$33.96 Million ≈ $24.03 Million	+0.45pp
2023-12-31	2.18%	AU$556.49K ≈ $393.75K	AU$25.55 Million ≈ $18.08 Million	--

pp = percentage points

About EZZ Life Science Holdings Ltd

AU:EZZ Australia Biotechnology

Market Cap

$10.15 Million

AU$14.35 Million AUD

Market Cap Rank

#26877 Global

#1241 in Australia

Share Price

AU$0.31

Change (1 day)

+0.00%

52-Week Range

AU$0.30 - AU$2.52

All Time High

AU$4.93